Discuss a hypothetical patient case, including symptom presentation, diagnosis, and management goals  Provide an overview of the cardiomyopathy of transthyretin-mediated amyloidosis (ATTR-CM)  Review the mechanism of action for AMVUTTRA  Review the clinical profile of AMVUTTRA for the treatment of ATTR-CM  Review AMVUTTRA access and support